KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Humana (HUM) over the last 17 years, with Q3 2025 value amounting to -$971.0 million.

  • Humana's Change in Account Payables fell 20249.22% to -$971.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 billion, marking a year-over-year decrease of 21151.78%. This contributed to the annual value of $199.0 million for FY2024, which is 7825.14% down from last year.
  • Humana's Change in Account Payables amounted to -$971.0 million in Q3 2025, which was down 20249.22% from -$391.0 million recorded in Q2 2025.
  • Over the past 5 years, Humana's Change in Account Payables peaked at $1.5 billion during Q1 2024, and registered a low of -$971.0 million during Q3 2025.
  • Moreover, its 5-year median value for Change in Account Payables was $27.0 million (2022), whereas its average is $96.9 million.
  • Its Change in Account Payables has fluctuated over the past 5 years, first surged by 26385.54% in 2022, then plummeted by 162222.22% in 2024.
  • Humana's Change in Account Payables (Quarter) stood at -$469.0 million in 2021, then skyrocketed by 105.76% to $27.0 million in 2022, then soared by 66.67% to $45.0 million in 2023, then crashed by 1622.22% to -$685.0 million in 2024, then tumbled by 41.75% to -$971.0 million in 2025.
  • Its Change in Account Payables stands at -$971.0 million for Q3 2025, versus -$391.0 million for Q2 2025 and $1.0 billion for Q1 2025.